Search

Your search keyword '"Sarubbi, B"' showing total 485 results
Start Over Author "Sarubbi, B"
485 results on '"Sarubbi, B"'

1. Myocardial work in systemic right ventricle: new insights on right ventricular adaptation to systolic flow

Author

Sorice, D, primary, Fusco, F, additional, Scognamiglio, G, additional, Abbate, M, additional, Merola, A, additional, Palma, M, additional, Grimaldi, N, additional, Barracano, R, additional, Borrelli, N, additional, Ciriello, G D, additional, Roma, A S, additional, Colonna, D, additional, Correra, A, additional, Romeo, E, additional, and Sarubbi, B, additional

Published
2023
Full Text
View/download PDF

3. Dapaglifozin in adults with a systemic right ventricle:initial results from the DAPA-SERVE trial

Author

Abbate, M, primary, Fusco, F, additional, Scognamiglio, G, additional, Merola, A, additional, Palma, M, additional, Grimaldi, N, additional, Barracano, R, additional, Borrelli, N, additional, Ppaccioli, G, additional, Sorice, D, additional, Roma, A S, additional, Colonna, D, additional, Correra, A, additional, Romeo, E, additional, and Sarubbi, B, additional

Published
2023
Full Text
View/download PDF

5. End-stage heart failure in congenitally corrected transposition of the great arteries:a multicentre study

Author

van Dissel, AC, Opotowsky, AR, Burchill, LJ, Aboulhosn, J, Grewal, J, Lubert, AM, Antonova, P, Shah, S, Cotts, T, John, AS, Kay, WA, DeZorzi, C, Magalski, A, Han, F, Baker, D, Kay, J, Yeung, ELZB, Vonder Muhll, I, Pylypchuk, S, Kuo, MC, Nicolarsen, J, Sarubbi, B, Fusco, F, Jameson, SM, Cramer, J, Gupta, T, Gallego, P, O'Donnell, C, Hannah, J, Dellborg, M, Kauling, RM, Ginde, S, Krieger, EV, Rodriguez, F, Dehghani, P, Kutty, S, Wong, JS, Wilson, WM, Rodriguez-Monserrate, CP, Roos-Hesselink, J, Celermajer, DS, Khairy, P, Broberg, CS, van Dissel, AC, Opotowsky, AR, Burchill, LJ, Aboulhosn, J, Grewal, J, Lubert, AM, Antonova, P, Shah, S, Cotts, T, John, AS, Kay, WA, DeZorzi, C, Magalski, A, Han, F, Baker, D, Kay, J, Yeung, ELZB, Vonder Muhll, I, Pylypchuk, S, Kuo, MC, Nicolarsen, J, Sarubbi, B, Fusco, F, Jameson, SM, Cramer, J, Gupta, T, Gallego, P, O'Donnell, C, Hannah, J, Dellborg, M, Kauling, RM, Ginde, S, Krieger, EV, Rodriguez, F, Dehghani, P, Kutty, S, Wong, JS, Wilson, WM, Rodriguez-Monserrate, CP, Roos-Hesselink, J, Celermajer, DS, Khairy, P, and Broberg, CS

Abstract

BACKGROUND AND AIMS: For patients with congenitally corrected transposition of the great arteries (ccTGA), factors associated with progression to end-stage congestive heart failure (CHF) remain largely unclear. METHODS: This multicentre, retrospective cohort study included adults with ccTGA seen at a congenital heart disease centre. Clinical data from initial and most recent visits were obtained. The composite primary outcome was mechanical circulatory support, heart transplantation, or death. RESULTS: From 558 patients (48% female, age at first visit 36 ± 14.2 years, median follow-up 8.7 years), the event rate of the primary outcome was 15.4 per 1000 person-years (11 mechanical circulatory support implantations, 12 transplantations, and 52 deaths). Patients experiencing the primary outcome were older and more likely to have a history of atrial arrhythmia. The primary outcome was highest in those with both moderate/severe right ventricular (RV) dysfunction and tricuspid regurgitation (n = 110, 31 events) and uncommon in those with mild/less RV dysfunction and tricuspid regurgitation (n = 181, 13 events, P < .001). Outcomes were not different based on anatomic complexity and history of tricuspid valve surgery or of subpulmonic obstruction. New CHF admission or ventricular arrhythmia was associated with the primary outcome. Individuals who underwent childhood surgery had more adverse outcomes than age- and sex-matched controls. Multivariable Cox regression analysis identified older age, prior CHF admission, and severe RV dysfunction as independent predictors for the primary outcome. CONCLUSIONS: Patients with ccTGA have variable deterioration to end-stage heart failure or death over time, commonly between their fifth and sixth decades. Predictors include arrhythmic and CHF events and severe RV dysfunction but not anatomy or need for tricuspid valve surgery.

Published
2023

6. Gravidanza e cardiopatie: il ruolo del Pregnancy Heart Team

Author

Parrini, I., Luca, F., Favilli, S., Domenicucci, S., Russo, M.G., Sarubbi, B., Gelsomino, S., Colivicchi, F., Gulizia, M.M., CTC, and RS: Carim - V04 Surgical intervention

Subjects
SCIENTIFIC STATEMENT, VENOUS THROMBOEMBOLISM, Acquired heart disease, PERIPARTUM CARDIOMYOPATHY, HYPERTROPHIC CARDIOMYOPATHY, HYPERTENSIVE DISORDERS, CARDIOVASCULAR-DISEASE, FAILURE ASSOCIATION, CARDIAC-DISEASE, Pregnancy Heart Team, EUROPEAN-SOCIETY, Congenital heart disease, TASK-FORCE
Abstract

A significant risk of maternal and fetal morbidity and mortality has been shown to be associated with congenital heart disease or heart disease occurring during pregnancy. Given the increasing number of patients with corrected congenital heart disease who reach fertile age and the more and more common advanced maternal age associated with preexisting or intercurrent comorbidities, a higher incidence of cardiac complications in pregnancy has been reported in the last decades. Improvement in maternal and neonatal outcomes is influenced by a multidisciplinary strategy. The purpose of this review is to assess the role of the Pregnancy Heart Team which should ensure careful pre-pregnancy counseling, pregnancy monitoring, and delivery planning for both congenital heart disease and other cardiac or metabolic disorders.

Published
2022

8. Myocardial work impairment in children with Wolff-Parkinson-White syndrome

Author

Borrelli, N, primary, Di Salvo, G, additional, Ciriello, G D, additional, Sabatino, J, additional, Grimaldi, N, additional, Barracano, R, additional, Fusco, F, additional, Merola, A, additional, Correra, A, additional, Romeo, E, additional, Colonna, D, additional, Palma, M, additional, Scognamiglio, G, additional, Russo, M G, additional, and Sarubbi, B, additional

Published
2022
Full Text
View/download PDF

10. External validation of a risk score model for predicting major clinical events in adults after atrial switch

Author

Albertini, M., primary, Fusco, F., additional, Sarubbi, B., additional, Gallego, P., additional, Rodriguez-Puras, M.J., additional, Prokselj, K., additional, Kauling, M., additional, Roos-Hesselink, J., additional, Labombarda, F., additional, Van De Bruaene, A., additional, Santes, B., additional, Buts, W., additional, Iserin, L., additional, Woudstra, O., additional, Bouma, B., additional, and Ladouceur, M., additional

Published
2022
Full Text
View/download PDF

14. Impaired myocardial work in paediatric patients with wolff-parkinson-white syndrome

Author

Borrelli, N, primary, Di Salvo, G, additional, Ciriello, GD, additional, Sabatino, J, additional, Bucciarelli, V, additional, Grimaldi, N, additional, Barracano, R, additional, Fusco, F, additional, Merola, A, additional, Correra, A, additional, Romeo, E, additional, Palma, M, additional, Scognamiglio, G, additional, Russo, MG, additional, and Sarubbi, B, additional

Published
2022
Full Text
View/download PDF

16. The management of adult congenital heart disease in the emergency department. The Task Force from the Italian Society of Pediatric Cardiology and Congenital Heart Disease

Author

Gagliardi M. G., Barracano R., Palmieri R., Chessa M., Ferraris L., Sarubbi B., D'Alto M., Assenza G. E., Donti A., Gagliardi, M. G., Barracano, R., Palmieri, R., Chessa, M., Ferraris, L., Sarubbi, B., D'Alto, M., Assenza, G. E., and Donti, A.

Subjects
Adult, Heart Defects, Congenital, Emergency department, Cardiology, Eisenmenger syndrome, Heart failure, Arrhythmias, Cardiac, Arrhythmias, Italy, Pregnancy, Humans, Adult congenital heart disease, Infective endocarditis, Child, Emergency Service, Hospital
Abstract

Over recent years, thanks to remarkable advances in pediatric cardiology, cardiac surgery and catheter interventions, survival of children with congenital heart disease has significantly increased with the majority of patients surviving into adulthood. Therefore, the prevalence of adult patients with congenital heart disease has dramatically increased, as well as the need for specific and dedicated programs. Acute heart failure, infective endocarditis and arrhythmias represent the most common causes of visit in the emergency department in this population. Our task force aimed at guiding physicians taking care of this peculiar cohort of patients in the emergency department.

Published
2021

17. Prognostic relevance of thyroid disease in adults with congenital heart disease

Author

Fusco, F, primary, Scognamiglio, G, additional, Guarguagli, S, additional, Merola, A, additional, Palma, M, additional, Borrelli, N, additional, Barracano, R, additional, Grimaldi, N, additional, Correra, A, additional, Piccolo, G, additional, La Rocca, F, additional, Del Giudice, C, additional, Colonna, D, additional, Romeo, E, additional, and Sarubbi, B, additional

Published
2021
Full Text
View/download PDF

18. The adding value of fluid challenge and balloon occlusion tests in patients with atrial septal defect

Author

D'Alto, M, primary, Chessa, M, additional, Santoro, G, additional, Giordano, M, additional, Gaio, G, additional, Romeo, E, additional, Argiento, P, additional, Wacker, J, additional, D'Aiello, F, additional, Sarubbi, B, additional, Russo, M G, additional, Golino, P, additional, Costantine, A, additional, Naeije, R, additional, and Dimopoulos, K, additional

Published
2021
Full Text
View/download PDF

19. Effects of sacubitril/valsartan in patients with a systemic right ventricle: early evidence of exercise tolerance and systolic function improvement

Author

Fusco, F, primary, Merola, A, additional, Scognamiglio, G, additional, Palma, M, additional, Correra, A, additional, Barracano, R, additional, Borrelli, N, additional, Grimaldi, N, additional, Spinelli Barrile, C, additional, Puzone, N, additional, Ciriello, G D, additional, Colonna, D, additional, Romeo, E, additional, and Sarubbi, B, additional

Published
2021
Full Text
View/download PDF

20. Electrophysiological Study Prognostic Value and Long-Term Outcome in Drug-Induced Type 1 Brugada Syndrome: The IBRYD Study

Author

Russo, V., Pafundi, P. C., Caturano, A., Dendramis, G., Ghidini, A. O., Santobuono, V. E., Sciarra, L., Notarstefano, P., Rucco, M. A., Attena, E., Floris, R., Romeo, E., Sarubbi, B., Nigro, G., D'Onofrio, A., Calo, L., and Nesti, M.

Subjects
electrophysiological study, implantable cardioverter-defibrillator, arrhythmia, Brugada syndrome, drug-induced type 1 Brugada syndrome, sudden cardiac death
Published
2021

21. Unexplained sudden cardiac arrest in children: clinical and genetic characteristics of survivors

Author

Monda, E, Sarubbi, B, Russo, M, Caiazza, M, Mazzaccara, C, Magrelli, J, Rubino, M, Esposito, A, Perna, A, Passariello, A, Bossone, E, Romeo, E, Colonna, D, Esposito, M, D'Argenio, V, Salvatore, F, Pacileo, G, Crotti, L, Frisso, G, Limongelli, G, Russo, MG, Esposito, MV, Limongelli, G., Monda, E, Sarubbi, B, Russo, M, Caiazza, M, Mazzaccara, C, Magrelli, J, Rubino, M, Esposito, A, Perna, A, Passariello, A, Bossone, E, Romeo, E, Colonna, D, Esposito, M, D'Argenio, V, Salvatore, F, Pacileo, G, Crotti, L, Frisso, G, Limongelli, G, Russo, MG, Esposito, MV, and Limongelli, G.

Published
2021

24. Italian Validation of the Healthcare Needs Scale for Youth with Congenital Heart Disease and Its Short-Form Development

Author

Dellafiore, F, Flocco, Sf, Arrigoni, C, Barello, Serena, Nania, T, Russo, Mg, Sarubbi, B, Magon, A, Pittella, F, Chessa, M, Caruso, R, Barello, S (ORCID:0000-0002-8514-2563), Dellafiore, F, Flocco, Sf, Arrigoni, C, Barello, Serena, Nania, T, Russo, Mg, Sarubbi, B, Magon, A, Pittella, F, Chessa, M, Caruso, R, and Barello, S (ORCID:0000-0002-8514-2563)

Abstract

Aims: This study aimed at providing an Italian short version of the 'healthcare needs scale for youth with congenital heart disease' (I-HNS-CHD-s), describing its construct validity and reliability. Methods: A multi-method and multi-phase design were adopted. Phase one referred to the cultural-linguistic validation of the original scale into Italian Phase two tasted content and face validity of the Italian-translated scale. Phase three included the psychometric validation process of scale, encompassed two different steps: first cross-sectional data collection (sample A) purposed at determining the psychometric characteristics of the I-HNS-CHD-s, using an exploratory factor analysis (EFA). Then, a second round of cross-sectional data collection (sample B) was performed using the version of I-HNS-CHD-s derived from the previous step, and it purposed at confirming the scale factor structure and at assessing its reliability. Results: IHNS-CHD-s showed evidence of face and content validity, adequate construct and internal consistency and stability. Specifically, I-HNS-CHD-s had 14 items kept by four domains, labelled as follows: Healthcare education, clinical support, emotional support, continuum of care. These domains were predicted by a secondorder factor, which was labelled as Healthcare needs. Overall I-HNS-CHD-s encompassed only the items that showed high performance in the psychometric analysis. Accordingly, I-HNS-CHD-s is a shorter form of the original scale (14 items instead of 25). Conclusions: I-HNS-CHD-s is a psychometrically robust measure of the healthcare and psychosocial needs of Italian adolescents and young adults with congenital heart disease.

Published
2020

25. Response to fluid challenge in patients with atrial septal defect

Author

D'Alto, M, primary, Chessa, M, additional, Gaio, G, additional, Santoro, G, additional, Giordano, M, additional, Romeo, E, additional, Argiento, P, additional, Wacker, J, additional, D'Aiello, F, additional, Sarubbi, B, additional, Russo, M.G, additional, Naeije, R, additional, and Golino, P, additional

Published
2020
Full Text
View/download PDF

32. Long term effects of bosentan treatment in adult patients with pulmonary arterial hypertension related to congenital heart disease (Eisenmenger physiology): safety, tolerability, clinical, and haemodynamic effect

Author

D'Alto, M., Vizza, C.D., Romeo, E., Badagliacca, R., Santoro, G., Poscia, R., Sarubbi, B., Mancone, M., Argiento, P., Ferrante, F., Russo, M.G., Fedele, F., and Calabro, R.

Subjects
Pulmonary hypertension -- Care and treatment, Bosentan -- Dosage and administration, Bosentan -- Research, Health
Published
2007

34. Prognostic value of intra-left ventricular electromechanical asynchrony in patients with mild hypertrophic cardiomyopathy compared with power athletes

Author

D'Andrea, A., Caso, P., Cuomo, S., Salerno, G., Scarafile, R., Mita, C., De Corato, G., Sarubbi, B., Scherillo, M., Calabro, R., and Citro, R.

Subjects
Cardiomyopathy, Hypertrophic -- Diagnosis, Athletic heart syndrome -- Diagnosis, Doppler echocardiography -- Usage, Doppler echocardiography -- Research, Heart ventricle, Left -- Physiological aspects, Heart ventricle, Left -- Medical examination, Health, Sports and fitness
Published
2006

41. Efficacy and safety of dabigatran in a 'real-life' population at high thromboembolic and hemorrhagic risk: data from MonaldiCare registry

Author

Russo V, Bianchi V, Cavallaro C, Vecchione F, De Vivo S, Santangelo L, Sarubbi B, paolo calabrò, Nigro G, D'Onofrio A, Russo, V, Bianchi, V, Cavallaro, C, Vecchione, F, De Vivo, S, Santangelo, Lucio, Sarubbi, B, Calabro', Paolo, Nigro, Gerardo, and D'Onofrio, A.

Subjects
Male, Hemorrhage, Middle Aged, Antithrombins, Dabigatran, Cohort Studies, Stroke, Treatment Outcome, Italy, Risk Factors, Population Surveillance, Thromboembolism, Atrial Fibrillation, Prevalence, cardiovascular system, Humans, Female, Prospective Studies, Registries, cardiovascular diseases, Dyspepsia, Aged, Follow-Up Studies
Abstract

Dabigatran is a novel target specific oral anticoagulant for stroke prevention in non valvular atrial fibrillation. Little is still known about its real-world effectiveness and safety in the italian population. Aim of our study was to evaluate the efficacy and safety of dabigatran in a large single-center cohort of "real-life" italian population with non-valvular AF and to compare the results with those obtained from the RE-LY trial and the Medicare study.We studied a prospective cohort of 2108 patients (1119 male; mean age 69.4 ± 9.4 years) who started the oral anticoagulant treatment with dabigatran 110 mg twice-daily (DAB 110; N = 1075; 51%) or 150 mg twice-daily (DAB 150; N = 1033; 49%). Follow-up data were obtained trough outpatients visits each 3-6 months for assessing the clinical status, adherence to treatment, occurrence of side effects and major cardiovascular complications.In DAB 150 group the mean age was 64.9 ± 8.8 years, 56.8% of patients was male. CHA2DS2Vasc Score was ≥ 3 in 94.3% and HAS-BLED was ≥ 3 in 59.7%. In DAB 110 group (N = 1075) the mean age was 73.9 ± 7.5 years; 49.5% of patients was male. CHA2DS2Vasc Score was ≥ 3 in 73.4% and HAS-BLED was ≥ 3 in 87.4% of DAB 110 patients. One patient taking Dabigatran 110 mg bid had ischemic stroke without significantly neurological sequelae. In both groups, no patient experienced hemorrhagic stroke during the follow-up period. 147 patients (6.9%) of MonaldiCare population reported adverse effects from treatment with dabigatran, of whom 121 patients (5.7%) discontinued therapy. We reported one case of subarachnoid hemorrhage (0.05%) in a patient with high thrombo-embolic and high hemorrhagic risk score who was taking dabigatran 150 mg bid and one case (0.05%) of bladder bleeding in a patient who was taking dabigatran 110 mg bid. No major gastrointestinal bleeding was observed in the MonaldiCare population.MonaldiCare registry showed a safety profile of both dosages of dabigatran regarding major of fatal bleeding in a "real life" single center italian population at high thromboembolic and hemorrhagic risk. The majority of MonaldiCare patients tolerated dabigatran treatment without significant side effects. The efficacy of dabigatran was demonstrated by very low prevalence of ictus/TIA, also when patients underwent electrical AF cardioversion independently of the transesophageal examination.

Published
2015

48. Impact of obesity on left ventricular geometry and function in pediatric patients after successful aortic coarctation repair

Author

Di Salvo, G., Gala, S., Castaldi, B., Baldini, L., Limongelli, G., D'Andrea, A., Scognamiglio, G., Sarubbi, B., Caso, P., Pacileo, G., Giovanna Russo, M., Calabro, R., DI SALVO, Giovanni, Gala, S, Castaldi, B, Baldini, L, Limongelli, Giuseppe, D'Andrea, A, Scognamiglio, G, Sarubbi, B, Caso, P, Pacileo, G, Giovanna Russo, M, and Calabro', Raffaele

Subjects
Male, Adolescent, Left, Blood Pressure, aortic coarctation, obesity, strain, ventricular function, Aortic Coarctation, Echocardiography, Female, Humans, Obesity, Ventricular Dysfunction, Left, Ventricular Dysfunction
Abstract

AIMS: To evaluate if obesity has an additional negative impact on left ventricular (LV) geometry and function in normotensive pediatric patients >12 months after successful treatment of aortic coarctation (CoA). METHODS AND RESULTS: We studied 40 CoA patients (mean age 14 ± 3 years, and male sex 70%), of them 10 were obese and 30 lean. Both groups were age and sex comparable. The entire studied sample underwent 24-ambulatory blood pressure (BP) monitoring, standard echocardiographic evaluation, and speckle tracking study. Both office and 24-hour diastolic BP were significantly increased in obese patients. Obese CoA patients showed increased LV mass (52 ± 13 g/m(2.7) vs. 43 ± 9 g/m(2.7) , P = 0.02), and significant reduction in E/A compared with lean CoA patients. Myocardial deformation properties were significantly reduced in obese CoA patients in all the three studied planes (longitudinal, radial, and circumferential) compared with CoA lean patients. LV twist values showed a significant reduction in the obese CoA group (9.9° ± 2.2° vs. 14.5° ± 2.3°, P < 0.0001). CONCLUSIONS: Our study shows that obesity in successfully treated CoA children, has an additional negative effect on BP, LV mass, and cardiac function. These findings are of particular concern, since life expectancy in CoA patients is limited mainly by atherosclerosis, and all the obesity-associated abnormalities found are harbingers of higher cardiovascular risk.

Published
2011

49. Congenital and acquired valvular disease

Author

Colonna P., Zeppilli P., D'Andrea A., Bianca I., Bria S., Calabro R., Calzolari A., Pozzi M., Sarubbi B., Vignati G., GARGIULO, GAETANO DOMENICO, PICCHIO, FERNANDO MARIA, Colonna P., Zeppilli P., D'Andrea A., Bianca I., Bria S., Calabro R., Calzolari A., Gargiulo G., Picchio F. M., Pozzi M., Sarubbi B., and Vignati G.

Subjects
Settore M-EDF/01 - METODI E DIDATTICHE DELLE ATTIVITÀ MOTORIE, CORONARY-ARTERY, MANAGEMENT, HEART-DISEASE, ARTERIAL SWITCH OPERATION, TASK-FORCE
Abstract

not evalable

Published
2010

50. Consensus Statement of Multisocietary Task Force Prescription of physical exercise in the cardiological environment--executive summary (fourth part)

Author

Giada F, Carlon R, vona M, Fattirolli F, De Piccoli B, Zeppilli P, Picchio FM, Colonna P, Calzolari A, Sarubbi B, Berrettini U, Vignati G, Andreozzi GM, Leone A, De Francesco A, Guglielmi R, Perticone F, Deste D, Simplicio S, D'Andrea L, Guiducci U, Di Francesco A, Federazione Medico Sportiva Italiana, Società Italiana di Cardiologia dello Sport, Associazione Nazionale Cardiologi Extra Ospedalieri, Associazione Nazionale Medici Cardiologi Ospedalieri, Gruppo Italiano di Cardiologia Riabilitativa, Società Italiana di Cardiologia, CALABRO', Raffaele, Giada, F, Carlon, R, Vona, M, Fattirolli, F, De Piccoli, B, Zeppilli, P, Picchio, Fm, Calabro', Raffaele, Colonna, P, Calzolari, A, Sarubbi, B, Berrettini, U, Vignati, G, Andreozzi, Gm, Leone, A, De Francesco, A, Guglielmi, R, Perticone, F, Deste, D, Simplicio, S, D'Andrea, L, Guiducci, U, Di Francesco, A, Federazione Medico Sportiva, Italiana, Società Italiana di Cardiologia dello, Sport, Associazione Nazionale Cardiologi Extra, Ospedalieri, Associazione Nazionale Medici Cardiologi, Ospedalieri, Gruppo Italiano di Cardiologia, Riabilitativa, and Società Italiana di, Cardiologia

Published
2007

Catalog

Books, media, physical & digital resources
See catalog results